167 related articles for article (PubMed ID: 26643012)
1. Continuous event monitoring via a Bayesian predictive approach.
Di J; Wang D; Brashear HR; Dragalin V; Krams M
Pharm Stat; 2016; 15(2):109-22. PubMed ID: 26643012
[TBL] [Abstract][Full Text] [Related]
2. An extension of Bayesian predictive sample size selection designs for monitoring efficacy and safety.
Teramukai S; Daimon T; Zohar S
Stat Med; 2015 Sep; 34(22):3029-39. PubMed ID: 26038148
[TBL] [Abstract][Full Text] [Related]
3. Bayesian predictive approach to interim monitoring in clinical trials.
Dmitrienko A; Wang MD
Stat Med; 2006 Jul; 25(13):2178-95. PubMed ID: 16007570
[TBL] [Abstract][Full Text] [Related]
4. A Bayesian meta-analytic approach for safety signal detection in randomized clinical trials.
Odani M; Fukimbara S; Sato T
Clin Trials; 2017 Apr; 14(2):192-200. PubMed ID: 28059578
[TBL] [Abstract][Full Text] [Related]
5. Predictive checking for Bayesian interim analyses in clinical trials.
Daimon T
Contemp Clin Trials; 2008 Sep; 29(5):740-50. PubMed ID: 18571477
[TBL] [Abstract][Full Text] [Related]
6. Monitoring event times in early phase clinical trials: some practical issues.
Thall PF; Wooten LH; Tannir NM
Clin Trials; 2005; 2(6):467-78. PubMed ID: 16422307
[TBL] [Abstract][Full Text] [Related]
7. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.
Lewis RJ; Lipsky AM; Berry DA
Clin Trials; 2007; 4(1):5-14. PubMed ID: 17327241
[TBL] [Abstract][Full Text] [Related]
8. Control charts for monitoring accumulating adverse event count frequencies from single and multiple blinded trials.
Gould AL
Stat Med; 2016 Dec; 35(30):5561-5578. PubMed ID: 27619565
[TBL] [Abstract][Full Text] [Related]
9. Bayesian hierarchical modeling for detecting safety signals in clinical trials.
Xia HA; Ma H; Carlin BP
J Biopharm Stat; 2011 Sep; 21(5):1006-29. PubMed ID: 21830928
[TBL] [Abstract][Full Text] [Related]
10. Bayesian approach to noninferiority trials for proportions.
Gamalo MA; Wu R; Tiwari RC
J Biopharm Stat; 2011 Sep; 21(5):902-19. PubMed ID: 21830922
[TBL] [Abstract][Full Text] [Related]
11. Joint monitoring and prediction of accrual and event times in clinical trials.
Zhang X; Long Q
Biom J; 2012 Nov; 54(6):735-49. PubMed ID: 22907686
[TBL] [Abstract][Full Text] [Related]
12. Bayesian adjusted R2 for the meta-analytic evaluation of surrogate time-to-event endpoints in clinical trials.
Renfro LA; Shi Q; Sargent DJ; Carlin BP
Stat Med; 2012 Apr; 31(8):743-61. PubMed ID: 22161275
[TBL] [Abstract][Full Text] [Related]
13. A Bayesian non-inferiority approach using experts' margin elicitation - application to the monitoring of safety events.
Aupiais C; Alberti C; Schmitz T; Baud O; Ursino M; Zohar S
BMC Med Res Methodol; 2019 Sep; 19(1):187. PubMed ID: 31533631
[TBL] [Abstract][Full Text] [Related]
14. Modeling of experts' divergent prior beliefs for a sequential phase III clinical trial.
Moatti M; Zohar S; Facon T; Moreau P; Mary JY; Chevret S
Clin Trials; 2013 Aug; 10(4):505-14. PubMed ID: 23820061
[TBL] [Abstract][Full Text] [Related]
15. A Bayesian-frequentist two-stage single-arm phase II clinical trial design.
Dong G; Shih WJ; Moore D; Quan H; Marcella S
Stat Med; 2012 Aug; 31(19):2055-67. PubMed ID: 22415966
[TBL] [Abstract][Full Text] [Related]
16. Predictive probability of success and the assessment of futility in large outcomes trials.
Trzaskoma B; Sashegyi A
J Biopharm Stat; 2007; 17(1):45-63. PubMed ID: 17219755
[TBL] [Abstract][Full Text] [Related]
17. A practical guide to Bayesian group sequential designs.
Gsponer T; Gerber F; Bornkamp B; Ohlssen D; Vandemeulebroecke M; Schmidli H
Pharm Stat; 2014; 13(1):71-80. PubMed ID: 24038922
[TBL] [Abstract][Full Text] [Related]
18. Group sequential control of overall toxicity incidents in clinical trials - non-Bayesian and Bayesian approaches.
Yu J; Hutson AD; Siddiqui AH; Kedron MA
Stat Methods Med Res; 2016 Feb; 25(1):64-80. PubMed ID: 22407172
[TBL] [Abstract][Full Text] [Related]
19. A Bayesian prediction model between a biomarker and the clinical endpoint for dichotomous variables.
Jiang Z; Song Y; Shou Q; Xia J; Wang W
Trials; 2014 Dec; 15():500. PubMed ID: 25528466
[TBL] [Abstract][Full Text] [Related]
20. Predictive probability methods for interim monitoring in clinical trials with longitudinal outcomes.
Zhou M; Tang Q; Lang L; Xing J; Tatsuoka K
Stat Med; 2018 Jun; 37(14):2187-2207. PubMed ID: 29664214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
